Grand Round Table emails primary care providers a daily summary about their scheduled patient follow-ups so they can better manage high-risk patients, keeping them out of the hospital. During the DHA, Grand Round Table saw first revenues and joined the Athena Marketplace.
Graphwear Technologies has developed the first graphene patch which measures dehydration, glucose, and lactic acid levels, all from your sweat. While in the DHA, GraphWear was accepted into Plug & Play VC in Silicon Valley, partnered with a wearable device company, and signed an agreement with the Philadelphia Eagles to provice analytic patches to players. They also closed a successful bridge round.
InvisAlert Solutions uses a wearable device to help care providers monitor patients in institutional settings, improving compliance. During the DHA, InvisAlert saw first revenues, launched multiple pilots, and submitted a new provisional patent. They also secured a distribution agreement.
Oncora Medical has a tool for planning personalized cancer radiotherapy that reduces the incidence of toxic radiation side effects in patients and improves cancer center efficiency. CEO was a finalist for Ernst & Young's Philadelphia Entrepreneur of the Year Award. Oncora presented at the the IMPACT Captial Conference and their abstract was accepted for the Annual Meeting of American Society for Radiation Oncology.
The One Health Company helps to enroll ill pets in trials of cutting-edge therapies, improving their wellness and helping to develop new therapies for human medicine. During the DHA program, CEO Christina K. Lopes was named to Bizwomen's 100 Women to Watch 2016, awarded Woman of Distinction by the Philadelphia Business Journal, and was interviewed at the World Economic Forum 2017 in Davos, Switzerland. The One Health Company was featured in The Economist (Nov. 12-18, 2016) and continues to take invesment while expanding their network of clinics.
Tissue Analytics transforms the smartphone into a platform for evaluating and measuring things like chronic wounds, burns, and skin conditions. While in the DHA, CEO Kevin Keenahan was honored with Philadelphia Business Journal's 2016 Healthcare Innovator Award. 2016 data shows use of their app in 83 facilities improved patient healing rates by nearly 4x.
Biomeme enables anyone to do mobile real-time DNA analysis. During their time at the DHA, they developed an extensive product line including: lab-free sample prep, 2 molecular test panels for personal genomics and STIs, mobile HW&SW that can detect up to 6 molecular targets, and a cloud-based web portal for data mgmt.
Curbside Care is the uber for healthcare delivery – housecalls are back! In the DHA, they launched a successful web-based MVP, started full product technology development, secured a unique medical malpractice insurance policy, and were awarded a pilot program with Jefferson Health.
Fever Smart is a smart patch thermometer that allows for continuous and remote temperature monitoring. In the DHA, they successfully launched the product in the market, won Entrepreneur Magazine’s College Entrepreneur of the Year, and launched their first clinical trial with Columbia University Neurosurgery Dept.
Fitly's first product is SmartPlate, the world's first intelligent plate that instantly analyses your entire meal with up to 99% accuracy. SmartPlate deploys deep learning algorithms, image recognition, and load sensory technology to identify, weigh and analyze meals within seconds. This enables users around the world to make well-informed, dietary decisions more easily which positively impacts their health.
SmartPlate has received overwhelming interests from top healthcare organizations, elite athletes, diabetes institutes, and many communities living with chronic diseases related to poor nutrition.
Keosys provides solutions and services for management, centralization and assessment of medical imaging in multicenter clinical trials. The DHA allowed them to establish presence and incorporate in PA, set up local marketing and operations, and obtain their first 2 major US clients.
Pulse Infoframe is a leading provider of health informatics software and services. Pulse has created breakthrough software with highly analytical services and a unique client network and operating model. Pulse focuses on the capture of “actionable little data” which is increasingly relevant for value based care. Patients, Providers, Payors and Pharmaceutical companies benefit from the deep insights these data can provide.
Pulse's unique patient engagement platform, which is fully mobile integrated with end-user driven visualization tools, has revolutionized the patient ecosystem to be inclusive and responsive. Pulse has built out 24 disease areas with key registries globally situated. Our flagship registry, the Global Melanoma Research Network (GMRN), was initiated in 2011 and has some of the most granular data regarding melanoma treatment regimens and outcomes available globally. Pulse plans to expand this registry and continue to expand in other disease areas and in the rare disease space.
Pulse is increasing its footprint in the US with a particular emphasis on strengthening its Philadelphia base. With DHA support, Pulse has grown more than 100% in 2015 over 2014, and its revenue and personnel are expected to grow significantly over the next 3 years.
UE LifeSciences Inc. (UELS) develops innovative yet low-cost and easy-to-use medical devices for breast cancer detection for underserved populations like women in developing countries and women with dense breasts.
UELS has validated iBreastExam device for clinical and usability effectiveness in a diverse range of environments and received its US FDA market clearance. They were selected by StartHealth in 2015.